{"id":{"repo_id":"bu","oai_identifier":"oai:open.bu.edu:2144/47412"},"canonical_url":"https://search.ndltd.org/etd/bu/oai:open.bu.edu:2144/47412","repository":{"repo_id":"bu","name":"Boston University","base_url":"https://open.bu.edu/oai/request"},"display":{"title":"Tuberculosis-driven heterologous immunity to HIV-1 and consequences in HIV-1 co-infection","abstract":"Mycobacterium tuberculosis (Mtb) is proven to augment protection against unrelated pathogens through enhanced antibody responses and epigenetic remodeling of innate immune cells. Although the role of Mtb on HIV-1 specific antibody responses has not been explored, the recognition of highly immunogenic antigens on Mtb may trigger a cascade of events culminating in an increased HIV-1 antigen presentation and specific B cell responses. Here, we compared HIV-1-specific antibody responses among people with HIV-1 either with or without active Mtb and simulated immune responses to HIV-1 infection and Mtb antigens using a tonsil organoid model. We examined HIV-1 specific neutralization and antibody-dependent cellular cytotoxicity (ADCC) breadth and potency (BP) among people with HIV-1 either with or without active Mtb (PWH/Active Mtb, PWH/Treated Mtb, and PWH/No Mtb). Before antiretroviral treatment (ART) and Mtb treatment, PWH/Active Mtb as compared to PWH/No Mtb demonstrated higher neutralization BP. During ART, PWH who developed new Mtb disease (PWH/Active Mtb) as compared to PWH/Treated Mtb and PWH/No Mtb had the highest fold increase in neutralization and ADCC BP. Neutralization BP did not associate with previously described determinants like HIV-1 virus levels, envelope diversity, and IgG concentrations, but associated with B cell cytokines (BAFF, APRIL, and IL-6) and ADCC BP. Our data suggest that active Mtb is associated with the augmentation of HIV-1 specific B cell responses before and during ART. Broad and potent anti-HIV-1 antibodies emerge from the germinal center activity in the lymph node. Mtb disease potentially exerts a bystander effect through cytokines on HIV-1 specific B and T cells. Additionally, Mtb disease may be broadening B cell responses by enhancing HIV-1 envelope expression. We used Mtb-derived antigens to simulate Mtb co-infection in HIV-1 infected human tonsils. HIV-1 infected as compared to HIV-1 infected and Mtb-antigen stimulated tonsil organoids had similar proportions of B and T cell subsets over 1 week in culture. HIV-1 infection led to the loss of CD4 T and T follicular helper cells in both groups. The tonsil organoid model may allow us to explore mechanisms underlying Mtb mediated enhancement of HIV-1 specific antibody responses in future studies.","abstract_html":"Mycobacterium tuberculosis (Mtb) is proven to augment protection against unrelated pathogens through enhanced antibody responses and epigenetic remodeling of innate immune cells. Although the role of Mtb on HIV-1 specific antibody responses has not been explored, the recognition of highly immunogenic antigens on Mtb may trigger a cascade of events culminating in an increased HIV-1 antigen presentation and specific B cell responses. Here, we compared HIV-1-specific antibody responses among people with HIV-1 either with or without active Mtb and simulated immune responses to HIV-1 infection and Mtb antigens using a tonsil organoid model. We examined HIV-1 specific neutralization and antibody-dependent cellular cytotoxicity (ADCC) breadth and potency (BP) among people with HIV-1 either with or without active Mtb (PWH/Active Mtb, PWH/Treated Mtb, and PWH/No Mtb). Before antiretroviral treatment (ART) and Mtb treatment, PWH/Active Mtb as compared to PWH/No Mtb demonstrated higher neutralization BP. During ART, PWH who developed new Mtb disease (PWH/Active Mtb) as compared to PWH/Treated Mtb and PWH/No Mtb had the highest fold increase in neutralization and ADCC BP. Neutralization BP did not associate with previously described determinants like HIV-1 virus levels, envelope diversity, and IgG concentrations, but associated with B cell cytokines (BAFF, APRIL, and IL-6) and ADCC BP. Our data suggest that active Mtb is associated with the augmentation of HIV-1 specific B cell responses before and during ART. Broad and potent anti-HIV-1 antibodies emerge from the germinal center activity in the lymph node. Mtb disease potentially exerts a bystander effect through cytokines on HIV-1 specific B and T cells. Additionally, Mtb disease may be broadening B cell responses by enhancing HIV-1 envelope expression. We used Mtb-derived antigens to simulate Mtb co-infection in HIV-1 infected human tonsils. HIV-1 infected as compared to HIV-1 infected and Mtb-antigen stimulated tonsil organoids had similar proportions of B and T cell subsets over 1 week in culture. HIV-1 infection led to the loss of CD4 T and T follicular helper cells in both groups. The tonsil organoid model may allow us to explore mechanisms underlying Mtb mediated enhancement of HIV-1 specific antibody responses in future studies.","abstract_has_math":false,"creators":["Adeoye, Bukola"],"institution":"Boston University","degree_name":"Doctor of Philosophy","degree_level":"doctoral","degree_discipline":"Microbiology","degree_department":null,"school":null,"contributors":[],"advisors":["Sagar, Manish"],"committee_chairs":[],"committee_members":[],"year":2023,"date_issued":"2023","date_published":"2023","updated_at":"2026-11-19T02:41:40Z","subjects":["Microbiology"],"languages":["en_US"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/2144/47412","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/2144/47412","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://open.bu.edu/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aopen.bu.edu%3A2144%2F47412","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Sagar, Manish"]},{"key":"dc:creator","label":"Author","values":["Adeoye, Bukola"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2023-11-03T15:07:10Z"]},{"key":"dc:date.embargo","label":"Dc Date Embargo","values":["2025-11-02T00:00:00Z"]},{"key":"dc:date.issued","label":"Date","values":["2023"]},{"key":"dc:date.updated","label":"Dc Date Updated","values":["2023-11-02T19:04:48Z"]},{"key":"dc:type","label":"Dc Type","values":["Thesis/Dissertation"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Microbiology"]},{"key":"thesis:degree_level","label":"Degree Level","values":["doctoral"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Doctor of Philosophy"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Boston University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Microbiology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/2144/47412"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Mycobacterium tuberculosis (Mtb) is proven to augment protection against unrelated pathogens through enhanced antibody responses and epigenetic remodeling of innate immune cells. Although the role of Mtb on HIV-1 specific antibody responses has not been explored, the recognition of highly immunogenic antigens on Mtb may trigger a cascade of events culminating in an increased HIV-1 antigen presentation and specific B cell responses. Here, we compared HIV-1-specific antibody responses among people with HIV-1 either with or without active Mtb and simulated immune responses to HIV-1 infection and Mtb antigens using a tonsil organoid model. We examined HIV-1 specific neutralization and antibody-dependent cellular cytotoxicity (ADCC) breadth and potency (BP) among people with HIV-1 either with or without active Mtb (PWH/Active Mtb, PWH/Treated Mtb, and PWH/No Mtb). Before antiretroviral treatment (ART) and Mtb treatment, PWH/Active Mtb as compared to PWH/No Mtb demonstrated higher neutralization BP. During ART, PWH who developed new Mtb disease (PWH/Active Mtb) as compared to PWH/Treated Mtb and PWH/No Mtb had the highest fold increase in neutralization and ADCC BP. Neutralization BP did not associate with previously described determinants like HIV-1 virus levels, envelope diversity, and IgG concentrations, but associated with B cell cytokines (BAFF, APRIL, and IL-6) and ADCC BP. Our data suggest that active Mtb is associated with the augmentation of HIV-1 specific B cell responses before and during ART. Broad and potent anti-HIV-1 antibodies emerge from the germinal center activity in the lymph node. Mtb disease potentially exerts a bystander effect through cytokines on HIV-1 specific B and T cells. Additionally, Mtb disease may be broadening B cell responses by enhancing HIV-1 envelope expression. We used Mtb-derived antigens to simulate Mtb co-infection in HIV-1 infected human tonsils. HIV-1 infected as compared to HIV-1 infected and Mtb-antigen stimulated tonsil organoids had similar proportions of B and T cell subsets over 1 week in culture. HIV-1 infection led to the loss of CD4 T and T follicular helper cells in both groups. The tonsil organoid model may allow us to explore mechanisms underlying Mtb mediated enhancement of HIV-1 specific antibody responses in future studies."]},{"key":"dc:title","label":"Title","values":["Tuberculosis-driven heterologous immunity to HIV-1 and consequences in HIV-1 co-infection"]}]}],"canonical_facts":{"dc:contributor.advisor":["Sagar, Manish"],"dc:creator":["Adeoye, Bukola"],"dc:date.accessioned":["2023-11-03T15:07:10Z"],"dc:date.embargo":["2025-11-02T00:00:00Z"],"dc:date.issued":["2023"],"dc:date.updated":["2023-11-02T19:04:48Z"],"dc:description.abstract":["Mycobacterium tuberculosis (Mtb) is proven to augment protection against unrelated pathogens through enhanced antibody responses and epigenetic remodeling of innate immune cells. Although the role of Mtb on HIV-1 specific antibody responses has not been explored, the recognition of highly immunogenic antigens on Mtb may trigger a cascade of events culminating in an increased HIV-1 antigen presentation and specific B cell responses. Here, we compared HIV-1-specific antibody responses among people with HIV-1 either with or without active Mtb and simulated immune responses to HIV-1 infection and Mtb antigens using a tonsil organoid model. We examined HIV-1 specific neutralization and antibody-dependent cellular cytotoxicity (ADCC) breadth and potency (BP) among people with HIV-1 either with or without active Mtb (PWH/Active Mtb, PWH/Treated Mtb, and PWH/No Mtb). Before antiretroviral treatment (ART) and Mtb treatment, PWH/Active Mtb as compared to PWH/No Mtb demonstrated higher neutralization BP. During ART, PWH who developed new Mtb disease (PWH/Active Mtb) as compared to PWH/Treated Mtb and PWH/No Mtb had the highest fold increase in neutralization and ADCC BP. Neutralization BP did not associate with previously described determinants like HIV-1 virus levels, envelope diversity, and IgG concentrations, but associated with B cell cytokines (BAFF, APRIL, and IL-6) and ADCC BP. Our data suggest that active Mtb is associated with the augmentation of HIV-1 specific B cell responses before and during ART. Broad and potent anti-HIV-1 antibodies emerge from the germinal center activity in the lymph node. Mtb disease potentially exerts a bystander effect through cytokines on HIV-1 specific B and T cells. Additionally, Mtb disease may be broadening B cell responses by enhancing HIV-1 envelope expression. We used Mtb-derived antigens to simulate Mtb co-infection in HIV-1 infected human tonsils. HIV-1 infected as compared to HIV-1 infected and Mtb-antigen stimulated tonsil organoids had similar proportions of B and T cell subsets over 1 week in culture. HIV-1 infection led to the loss of CD4 T and T follicular helper cells in both groups. The tonsil organoid model may allow us to explore mechanisms underlying Mtb mediated enhancement of HIV-1 specific antibody responses in future studies."],"dc:identifier.uri":["https://hdl.handle.net/2144/47412"],"dc:language.iso":["en_US"],"dc:subject":["Microbiology"],"dc:title":["Tuberculosis-driven heterologous immunity to HIV-1 and consequences in HIV-1 co-infection"],"dc:type":["Thesis/Dissertation"],"thesis:degree_discipline":["Microbiology"],"thesis:degree_level":["doctoral"],"thesis:degree_name":["Doctor of Philosophy"],"thesis:institution_name":["Boston University"]},"updated_at":"2026-11-19T02:41:40Z"}